Sagimet Biosciences Inc. SEC filings SGMT
Sagimet Biosciences Inc. has 262 filings in SEC EDGAR's recent list, going back to May 8, 2007. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 22, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 1, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Other events
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 21, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 3, 2026 | May 28, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Material agreement
|
Apr 28, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 27, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Apr 27, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 21, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 11, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 2, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 18, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Other events
|
Dec 17, 2025 | Dec 17, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Auditor change
|
Aug 22, 2025 | Aug 18, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 10, 2025 | Jun 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 4, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 30, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 12, 2025 | Mar 12, 2025 |
| 8-K |
Current report
Other events
|
Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Other events
|
Feb 14, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Other events
|
Jan 2, 2025 | Jan 2, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Material agreement
|
Aug 16, 2024 | Aug 15, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 1, 2024 | Jul 30, 2024 |
| 8-K |
Current report
Other events
|
Jul 2, 2024 | Jul 2, 2024 |
| 8-K/A |
Amended current report
Other events
|
Jun 13, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 6, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 23, 2024 | May 23, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Officer or director change
|
May 6, 2024 | May 3, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Mar 25, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 2, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Other events
|
Jan 30, 2024 | Jan 25, 2024 |
| 8-K |
Current report
Results of operations
|
Jan 24, 2024 | Jan 23, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 22, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 29, 2023 | Dec 28, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 21, 2023 | Nov 17, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2023 | Oct 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 27, 2023 | Sep 27, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 21, 2023 | Aug 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 27, 2023 | Jul 21, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 18, 2023 | Jul 18, 2023 |
Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SGMT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Foster City, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1400118
- Former names
- 3-V Biosciences, Inc. (until Feb 25, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.